Losing a Diagnosis Can Be Just as Difficult as Getting One

By Esca van Blarikom

When actor Christina Applegate revealed that she had been misdiagnosed with multiple sclerosis (MS), she described the experience as “very unnerving” and “really confusing”.

For five years, MS had provided an explanation for her symptoms. Now, although those symptoms remained, the diagnosis that had helped her make sense of them was gone.

“I haven’t gotten better… If anything, I’ve gotten worse in some ways,” she explained. She also described feeling that she had lost the “reason” that had helped her make sense of her daily struggles.

Being told you don’t have a disease might seem like good news. But for someone living with symptoms, losing a diagnosis can mean losing an explanation for their suffering, along with the hope that explanation provides.

My ethnographic research into the experiences of people living with multiple conditions helps explain why. Through interviews and observations, I explored how diagnoses shape people’s understanding of their symptoms, their expectations for treatment and their sense of what the future might hold.

One participant in my London-based study had spent years living with debilitating back pain, struggling to get out of bed in the morning. After tests and referrals, a rheumatologist suggested that her symptoms might have an inflammatory cause.

Although this was only a possible diagnosis, it changed how she understood her condition. The specialist introduced medical terms that helped her make sense of symptoms that seemed confusing and unpredictable.

For the first time, there appeared to be an explanation for her suffering. The possibility of identifying an inflammatory condition also offered hope of treatment and specialist care.

But that hope was short-lived. Weeks later, a scan showed no evidence of the suspected inflammation. She was discharged from the clinic without the answers she had hoped for.

Her symptoms had not disappeared, and in the months that followed, her mental health deteriorated markedly.

Unlike Applegate, this participant had never received a confirmed diagnosis that was subsequently withdrawn. But both experiences reveal how much can be invested in a medical explanation, even before it is established.

For the woman in my study, the disappointing test result meant losing a possible way forward after years of uncertainty.

How Diagnoses Shapes Experience

A diagnosis can influence much more than the treatment someone receives. It can also change how they interpret their symptoms and what they expect from their illness.

Research suggests that the attention we pay to bodily sensations can influence how we experience and report them.

In a 2024 experimental study, researchers found that repeatedly asking people about their symptoms increased the number they reported. This effect was particularly pronounced among people with higher levels of health anxiety or existing symptom distress.

These findings do not mean that symptoms are imagined or caused by receiving a diagnosis. They suggest that our awareness and interpretation of bodily sensations can be influenced by the circumstances in which we experience them.

A diagnosis can also create new fears.

When Applegate first received her MS diagnosis, she spoke about experiencing a profound depression and feeling fatalistic about her future.

People with physical health conditions have an increased risk of depression, although this can reflect many factors, including the effects of illness itself.

Another participant in my research described how her quality of life deteriorated after receiving a diagnosis of a chronic condition.

Before the diagnosis, her symptoms had been difficult to interpret. Afterwards, she increasingly understood them as possible signs of deterioration.

She felt that her quality of life had declined significantly following the diagnosis, rather than simply after the onset of her symptoms.

This illustrates how receiving a medical explanation can alter someone’s expectations about their future, particularly when a condition is presented as chronic or difficult to treat.

Research on nocebo effects offers one possible insight into the relationship between expectations and symptoms. Experimental studies have shown that negative expectations can increase experiences of pain through psychological and physiological processes.

This does not establish that the diagnosis caused my participant’s deterioration. However, it helps illustrate why the expectations surrounding illness deserve attention alongside its physical effects.

What Happens When the Diagnosis Disappears

A diagnosis can provide access to treatment, but it may also offer recognition, reassurance and a sense of belonging.

Applegate has spoken about finding support within the MS community. Losing her diagnosis therefore raised questions extending beyond her medical treatment, including her place within a community that had become important to her.

For people with persistent symptoms, the absence of a diagnosis can also create difficulties in having their experiences understood and taken seriously.

Researchers studying unexplained symptoms have highlighted the disadvantages people can face when they lack a shared explanation for what they are experiencing.

This is why a negative test result does not necessarily resolve a patient’s difficulties. It may rule out one possible cause while leaving the symptoms, and the need for care, unchanged.

The challenge for healthcare professionals is to communicate diagnostic uncertainty without leaving patients feeling abandoned.

A 2024 study of GP consultations found that doctors varied considerably in how they explained plans for managing uncertain diagnoses. Some offered detailed guidance, while others provided less information about what patients should do if symptoms persisted or worsened.

For patients who have lost a diagnosis, continuing care might involve explaining why the original diagnosis has changed, acknowledging the distress that this can cause and agreeing on the next steps for investigation or symptom management.

These conversations also need to recognise that ruling out a particular disease does not invalidate the symptoms someone continues to experience.

Applegate’s experience illustrates something important about the role diagnoses play in people’s lives. They can shape how we understand our bodies, our relationships with others and our expectations for the future.

When a diagnosis is withdrawn, those understandings may have to be rebuilt, even as the symptoms that prompted the original investigation continue.

For doctors, the responsibility does not end when a diagnosis is ruled out. Patients still need help making sense of what is happening to them, especially when medicine cannot yet provide a clear answer.

Esca van Blarikom, PhD, is a researcher of medical anthropology for the Department of Global Health & Social Medicine at King's College London.

This article originally appeared in The Conversation and is republished with permission.   

I Used to Believe 'Good' Health Insurance Was Actually Good. I Was Wrong

By Crystal Lindell

Chronic pain is not a patient teacher— especially when you combine it with a private health insurance system. 

I first developed debilitating chronic pain in 2013, and I’ve been learning to live with it ever since. Over the last 12 years, I’ve been forced to learn a lot about the realities of what it’s like to live in a country with a mostly private healthcare system.

While I am currently among the lucky few who are able to mostly manage my pain with daily opioid medications, I am also now among the 26 million people in the United States who don’t have any health insurance. As a result, I pay for all of my doctor visits and prescriptions in cash.

It wasn’t always this way though. 

When I first got sick, I had what I would have described as “good health insurance” through my job. I kept that insurance until I was laid off in 2022. But in those nine years, even with that insurance, I still managed to rack up more medical debt that I could ever pay off in my lifetime. 

Until I actually needed my insurance and learned how it works, I really did believe that having it would somehow shield me from drowning in medical debt.

I was wrong.

It turns out that even with good health insurance, you can still rack up thousands or even tens of thousands of dollars in medical bills pretty quickly — even without being hospitalized or undergoing surgery.

Having health insurance means you likely pay a relatively small co-pay for routine appointments — which is good when all you need are the routine appointments.

But the minute you start needing medical tests, specialist care, physical therapy, prescriptions, and ER visits? All bets are off.

It’s partly because many of those things are not covered by co-pay programs. They fall under extremely high deductible programs that can require you to spend thousands of dollars out of your own pocket before insurance kicks in. 

Co-pays can also add up fast when you need to see a different doctor every other week, and all of them prescribe you a different name-brand prescription and a different long-term treatment.

For example, if you have a $50 co-pay for every physical therapy appointment and you need physical therapy three times a week for 12 weeks – that’s suddenly $1,800 right there. 

Or if you need a prescription that doesn’t have a generic available, it can literally be hundreds of dollars each month just for a co-pay.

The first few years I had chronic pain, I was desperate for answers and help, so I saw every specialist I could and got every medical test and treatment that was offered to me. It made sense at the time. After all, wasn’t that the whole point of why I was paying hundreds of dollars a month in premiums for my good health insurance?

But the thing about all those doctor visits and treatments is that nobody ever discusses cost with you beforehand. Instead, you only find out when you get an enormous bill in the mail weeks or even months later. 

Suddenly, the simple X-ray means you somehow owe $3,000. 

I was not making much money at the time, and I make even less money now because I’ve had to scale back my life to accommodate my chronic pain. So a lot of those medical bills just ended up with medical collection agencies, which destroyed my credit. 

The frustrating thing is that most of the money I owe was for doctors who missed my eventual diagnosis of Ehlers-Danlos Syndrome, and for treatments that weren’t nearly as effective as cheap generic hydrocodone. 

But it didn’t matter that I was misdiagnosed or how little help I got from those treatments, because I still ended up with thousands of dollars of medical debt all the same.

I always say, everyone loves their private health insurance, right up until they actually need to use it. Then they find out just how little it actually covers.

We can do better in this country. Even incremental changes to regulations around insurance companies and medical billing practices would make a huge difference. And of course, there’s always the option of universal health care, which could be modeled after similar programs that most developed countries around the world already have. 

We have the most expensive healthcare system in the world, nearly $5 trillion annually or $14,570 per person. Much of its is spent on administration and insurance billing.

Nobody deserves to end up with thousands of dollars of medical debt just because they got sick. We must do better, because only then can patients focus on what really matters: Getting better.

Many Multiple Sclerosis Patients Misdiagnosed

By Pat Anson, Editor

Multiple Sclerosis (MS) is a chronic disease that attacks the body’s central nervous system, causing pain, numbness, difficulty walking, paralysis, loss of vision, and fatigue. Patients diagnosed with MS face enormous physical, emotional and financial challenges coping with a disease that cannot be cured.

Many also discover that they don’t actually have MS.

A new study published in the journal Neurology looks at 110 patients who were incorrectly diagnosed with MS when they actually suffered from more common and treatable conditions such as migraine and fibromyalgia.   

One third of the patients were misdiagnosed for a decade or longer, most took unnecessary and potentially harmful medication to treat a disease they didn't have, and some even participated in clinical trials for experimental MS therapies.

About a third suffered from “unnecessary morbidity” – morbid thoughts of death.

"Misdiagnosis of MS is common; patients may experience common MS symptoms, such as numbness and weakness with a variety of different conditions, many that are more common and less serious than multiple sclerosis," says the study's senior author Brian Weinshenker, MD, a neurologist at Mayo Clinic.

"With the advent of treatments for MS, many physicians feel pushed to reach an early diagnosis, and may be less strict than they should in requiring more specific symptoms or objective neurological findings before making a diagnosis of MS.”

Unlike other chronic illnesses, there is no specific biomarker or blood test for MS. The nerve damage caused by MS is also associated with a wide range of symptoms, many of which are also caused by other conditions such as Lyme disease, lupus, fibromyalgia, and Vitamin B12 deficiency.

Some diagnostic tests for MS, such as magnetic resonance imaging (MRI), can also be misinterpreted.

“Nonspecific MRI abnormalities that can mimic those of MS are very common in healthy individuals, and widespread use of MRI as a diagnostic tool increases the rate of misdiagnosis," said Weinshenker.

The 110 patients included in the study were identified by MS subspecialist neurologists at Mayo Clinic, University of Vermont, Washington University and Oregon Health & Science University.

Twenty two percent of the misdiagnosed patients actually had migraine; 15% had fibromyalgia; 12% had a nonspecific condition flagged by an abnormal MRI; 11% had a conversion or psychogenic disorder; and 6% had neuromyelitis optica spectrum disorder.

"This study suggests significant and long-term unnecessary risks for these patients," said lead author Andrew Solomon, MD, a neurologist at the University of Vermont College of Medicine. "While there may be different reasons for misdiagnoses by subspecialists and nonspecialists, this study suggests that we all make mistakes, and I think we can all do better.”

A previous survey of MS specialists found that more than 95% had seen at least one patient in the past year that was misdiagnosed with MS by another provider.

Some treatments for MS carry serious side effects. One drug, taken by 13 percent of the misdiagnosed patients in the current study, can cause a potentially fatal brain infection. Other patients suffered from the discomfort and inconvenience of daily injections; others experienced side effects from medications or lacked treatment for the conditions they actually had.

There are also enormous financial costs involved. The cost of medications to treat MS in the United States now exceeds $50,000 a year.

"Premature diagnosis of MS should be avoided," says Weinshenker. "When in doubt, physicians often can defer a diagnosis if it is not clear that there is a serious neurological problem or if a patient is stable. Physicians should request a second opinion when they are unsure but concerned that it might be harmful to delay a definitive diagnosis of MS."

Weinshenker and Solomon hope their study will encourage better education of clinicians on the proper use of MS diagnostic criteria and to further studies on how to recognize patients incorrectly diagnosed with MS.